A randomised controlled trial investigating the pharmacodynamic effect of TicagrElor Monotherapy on PLATElet reactivity in patients with coronary artery disease
Phase of Trial: Phase IV
Latest Information Update: 21 Dec 2018
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Coronary artery disease
- Focus Pharmacodynamics
- Acronyms TEMPLATE
- 15 Dec 2018 Status changed from active, no longer recruiting to completed.
- 09 Nov 2017 Trial design published in the Trials
- 16 Oct 2017 Status changed from recruiting to active, no longer recruiting.